News Detail
Mumbai, Naples, 11 Jan 2025: Global pharma major Lupin Limited (Lupin) today announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Ivacaftor Oral Granules, 25 mg, 50 mg, a......
View Details
Source : Lupin Ltd
cystic fibrosis
Lupin Limited
FDA tentative approval
Vertex Pharmaceuticals
generic drug exclusivity
generic equivalent
Ivacaftor Oral Granules
Related News
- Nepal drug regulator tells pharmacies to stop selling illegal food supplements and cosmetics (11-01-2025)
- Medtech industry expects regulatory body to reclassify more medical devices (11-01-2025)
- IDMA plans extensive workshops on revised Schedule M to assist pharma MSMEs (11-01-2025)
- Approvals for medical devices may ease with new classification (11-01-2025)
- Action against quack: 44 types of medicines seized, accused absconding (11-01-2025)
- Customs arrests exporter for smuggling tramadol to Africa (10-01-2025)
- Karnataka HM Dinesh Gundu Rao seeks reforms in drug regulatory framework (10-01-2025)
- Bacteria Use Natural Products to Expose Competitors to Viruses (10-01-2025)
- Centre to reclassify medical devices to bring regulatory uniformity (10-01-2025)
- TechInvention partners with Ethiopia’s Ministry of Health to advance vaccine manufacturing in Africa (10-01-2025)